Not exact matches
The Dr Hadwen Trust for Humane Research claims that «in some instances, reliance
on inaccurate animal «
models»
of human disease have undoubtedly delayed medical progress.»
With our
human gut -
on - a-chip, we can not only culture the normal gut microbiome for extended times, but we can also analyze contributions
of pathogens, immune cells, and vascular and lymphatic endothelium, as well as
model specific
diseases to understand complex pathophysiological responses
of the intestinal tract.»
These techniques include:
human tissue created by reprogramming cells from people with the relevant
disease (dubbed «patient in a dish»); «body
on a chip» devices, where
human tissue samples
on a silicon chip are linked by a circulating blood substitute; many computer
modelling approaches, such as virtual organs, virtual patients and virtual clinical trials; and microdosing studies, where tiny doses
of drugs given to volunteers allow scientists to study their metabolism in
humans, safely and with unsurpassed accuracy.
This discovery will solve one
of the key stumbling blocks in devising therapies: the lack
of a
human model that can shed light
on how the
disease progresses.
In order to test their hypothesis in a
model that more closely mimicked
human disease, the researchers also tested the two drugs side - by - side
on slices
of tumors removed from patients during radical prostatectomy.
Mardinoglu says the team's network
modeling approach, which relied
on data from the Sweden - based
Human Protein Atlas project and The Genotype - Tissue Expression (GTEx) project consortia, can be used in the identification
of drug targets and eventually in the development
of efficient strategies for treating a number
of chronic liver
diseases.
«If
human organs
on chips can be shown to be robust and consistently recapitulate complex
human organ physiology and
disease phenotypes in unrelated laboratories around the world, as suggested by early proof -
of - concept studies, then we will see them progressively replace one animal
model at a time.
His research focuses
on the cancer biology, drug resistance, and signaling pathway networks
of human diseases as well as
on ways to
model these disorders.
Such ease
of use will likely encourage the use
of more animal
models in the study
of human diseases, says Rhonda Wiler, a geneticist at biotech giant Genentech in San Francisco, California, who co-chairs the Roundtable
on Science and Welfare in Laboratory Animal Use (which organized the workshop).
«In the future, such efforts could allow us to much better understand
human - microbiome interactions,
model malnutrition disorders and inflammatory
diseases of the gut, and perform personalized drug testing,» said co-first author Alessio Tovaglieri, a Graduate Student at the Department
of Health Science and Technology at ETH Zurich in Switzerland, who performs his thesis work
on Ingber's team.
The new study is based
on the development
of mouse
models manifesting the
disease that causes megalencephaly, spasticity and ataxia in
humans.
Thank you for airing Joseph Garner's views
on the futility
of trying to cure mouse «
models»
of human diseases (29...
To determine the effect
of gastric acid suppression
on the progression
of chronic liver
disease, Schnabl's team looked at mouse
models that mimic alcoholic liver
disease, NAFLD and NASH in
humans.
Thomas W Geisber, an expert
on Ebola and siRNAs at The University
of Texas Medical Branch, said the research was «highly significant because it shows protection against Ebola in a robust
model of human disease: non-
human primates.»
«What we've shown in the monkey
model matches a lot
of what people have observed in epidemiological studies
of humans,» says Emma Mohr, a pediatric infectious
disease fellow at UW — Madison and first author
on the study with Matthew Aliota and Dawn Dudley, research scientists in UW — Madison's schools
of Veterinary Medicine and Medicine and Public Health, respectively.
Although further refinement and testing is needed, Dr. Burgess said the new techniques have the potential to speed the production
of many different types
of transgenic animal
models that will shed new light
on human development and
disease.
«Amy's video is both beautiful to watch
on an aesthetic level and beautiful to watch as an illustration
of how simple
model organisms like Ashbya can give us insights into
human diseases like Alzheimer's,» Atkinson continues.
Together, our results suggest a comprehensive
model of chromatin dynamics during development and set the foundation for similar work
on human blood formation and
disease.
PHENOMIN's involvement in the IMPC will fulfill a key item
of the the National Alliance for life sciences and health (AVIESAN) strategic plan that consists in applying mouse genetics to analyze the mechanisms
of disease and to use this knowledge for advancing fundamental research and
human health (AVIESAN report
on the use and needs
of mouse
models in the French scientific community, 2010).
In recent years, researchers have developed so - called «senolytic» drugs that wipe out senescent cells in aging mice and mouse
models of age - related
disease, exploiting the high dependence
of these cells
on specific biochemical survival pathways.9, 10 In these studies, senolytic drugs have restored exercise capacity9 and formation
of new blood and immune precursor cells11 in aging mice to near youthful norms, and prevented or treated mouse
models of diseases of aging like osteoarthritis, 12 fibrotic lung
disease, 13 hair loss, 14 atherosclerosis, 15,16 and age - related
diseases of the heart itself.9 UNITY Biotechnology is leading a growing charge toward the clinic, with
human clinical trials expected to begin in 2019.
We focus
on developing computational methods and tools for (a) analyzing large - scale gene expression data related to
human cancer in search for gene markers and
disease sub-categories, (b) identifying regulatory elements such as miRNA precursors and their targets in whole genomes
of plants and mammals, (c) building theoretical
models of gene regulatory networks.
Over the last few years, scientists have been able to recreate accurate
models of human organs by embedding living tissue onto chips, allowing them to study the effects
of drugs and
diseases without testing
on animals or
humans.
It should be noted, however, that while a study
on senescent cell ablation in genetically normal mice would provide at least some evidence
on the effect
of senescent cells (and their ablation)
on promoting cancer, even such a study would likely show less effect than could be anticipated in a large mammal
model, since even normally - aging mice rarely suffer metastatic
disease to the extent
of aging
humans, as sheer primary tumor volume is generally sufficient to be fatal to mice.
Moreover, PHENONIM - ICS is involved in European projects presenting a strong impact
on human health: Interreg CARDIOGENE (Genetic mechanisms
of cardiovascular
diseases), GENCODYS (Genetic and epigenetic networks involved in cognitive dysfunctions), AgedBrainSYSBIO (Basic studies
of brain aging), as well as projects in partnership with industry: MAGenTA (an Industrial Strategic Innovation project supported by Bpifrance about the treatment
of major urogenital
diseases) and CanPathPro (H2020 program), to develop a predictive
modeling platform
of signaling pathways involved in cancers.
The HTS at I - Stem focuses
on relevant biological
models of genetic
diseases: the
human stem cells and their progenies.
«Historically, we have had trouble
modeling human diseases caused by mutation
of just one copy
of a gene in mice, which impedes research
on complex conditions and limits our discovery
of therapeutics,» explained Srivastava, director
of the Gladstone Institute
of Cardiovascular
Disease and senior author
on the study.
In addition, projects to perform genetic interaction screens
on disease genes in
model organisms (yeast, worm, fly, fish) will not be considered, unless the project includes substantive specific aims that investigate the
disease relevance
of any new genes discovered in
human or mammalian
model systems.
These experiments are innovative because they seek to improve a mouse
model based
on current knowledge from
human disease, while also testing novel therapies that could be
of benefit for affected individuals.
WFSM establishes laboratory to develop transgenic and knockout mice to
model human disease and shed light
on function
of human genes.
His research focuses
on understanding the role
of genetic variation in contributing to
human health and
disease using mouse
models of human disease, and more recently exploiting technologies developed for biomedical research for application in the field
of genetic pest management.
The Ellerby lab is known for its pioneering studies
on Huntington's
disease (HD), and Karen is now using
human stem cell
models of HD to understand why important molecular signaling pathways, such as the TGF - β pathway, are dysregulated in HD.
These mouse
models could shed light
on a wide range
of human diseases such as diabetes, many types
of cancers, and even neurological
diseases such as depression.
I am currently working
on a variety
of NIH - funded projects, including areas such as bioinformatics research portals, visualization for review
of chart records, and tools for aiding the discovery
of animal
models of human diseases.
For three years now we have been working
on human cell
models of rare neurodegenerative
diseases with special emphasis
on neuroacanthocytosis, neuronal ceroid lipofuscinosis as well as motor neuron degeneration (using iPS cells).
Numerous mouse
models have been generated to examine the pathogenesis
of the
disease and to evaluate therapeutic approaches, but the most precise genetic reproductions
of the
human condition are the knock - in (KI) mouse
models which express the huntingtin mutation in the proper genetic and protein context
on the murine gene.
The work in
humans is complemented by laboratory work involving cell death in Parkinson's
disease, effects
of stimulation
on hippocampal neurogenesis and animal
models of deep brain stimulation.
«Given the long and established history
of curcumin as a spice and herbal medicine, its demonstrated chemopreventive and therapeutic potential, and its pharmacological safety in
model system, curcumin, the bioactive extract
of curcumin, promises a great future in
human clinical studies designed to prevent and / or delay age - related
diseases,» explained the authors
of a review
on these and other animal studies involving curcumin.
The Effect
of Acetyl - L - carnitine and R - alpha - lipoic acid Treatment in ApoE4 Mouse as a
Model of Human Alzheimer's Disease J Neurol Sci 2009 (Mar 31)[Epub ahead of print] We measured age - dependent effects of human ApoE4 on cerebral blood flow (CBF) using ApoE4 transgenic mice compared to age - matched wild - type (WT) mice by use of -LSB-(14) C] iodoantipyrene autoradiogr
Human Alzheimer's
Disease J Neurol Sci 2009 (Mar 31)[Epub ahead
of print] We measured age - dependent effects
of human ApoE4 on cerebral blood flow (CBF) using ApoE4 transgenic mice compared to age - matched wild - type (WT) mice by use of -LSB-(14) C] iodoantipyrene autoradiogr
human ApoE4
on cerebral blood flow (CBF) using ApoE4 transgenic mice compared to age - matched wild - type (WT) mice by use
of -LSB-(14) C] iodoantipyrene autoradiography.
Her address, «A New Medical Research
Model: Advancing Human and Animal Health Humanely,» will detail the concept of a new research model predicated on a meaningful commitment by both medical and veterinary researchers to work cooperatively together to address disease and disorders in humans and animals — evaluating genetic and environmental risk factors, sensitive diagnostic indicators and novel thera
Model: Advancing
Human and Animal Health Humanely,» will detail the concept
of a new research
model predicated on a meaningful commitment by both medical and veterinary researchers to work cooperatively together to address disease and disorders in humans and animals — evaluating genetic and environmental risk factors, sensitive diagnostic indicators and novel thera
model predicated
on a meaningful commitment by both medical and veterinary researchers to work cooperatively together to address
disease and disorders in
humans and animals — evaluating genetic and environmental risk factors, sensitive diagnostic indicators and novel therapies.
Oral administration
of Lactobacillus microbes has been demonstrated to have beneficial therapeutic effect in experimental
models of neurological
disease, as well as in recent clinical trials
on depression and anxiety disorders in
humans.
The emphasis is
on developing intellectual abilities and research skills through investigations
of infectious
diseases of food - producing, companion, and aquatic animals, as well as animal
models for
human disease.
Dr. Dodds has been a member
of many national and international committees
on hematology, animal
models of human disease, veterinary medicine and laboratory animal research.
Dr. Dodds has been a member
of many committees
on hematology, animal
models of human disease and veterinary medicine.
Current
models of climate change include sea level rise, land degradation, regional changes in temperature and precipitation patterns, and some consequences for agriculture, but without
modeling the feedbacks that these significant impacts would have
on the
Human System, such as geographic and economic displacement, forced migration, destruction of infrastructure, increased economic inequality, nutritional sustenance, fertility, mortality, conflicts, and spread of diseases or other human health consequences [135,
Human System, such as geographic and economic displacement, forced migration, destruction
of infrastructure, increased economic inequality, nutritional sustenance, fertility, mortality, conflicts, and spread
of diseases or other
human health consequences [135,
human health consequences [135,136].
It concentrates
on repairing damage within a
disease model of human functioning.